It turns out that a skull implant may be able to detect a seizure and provide therapeutic electrical impulses in rats that lessen the amount of seizures by as much as 60 percent. This new research may also work in humans, and the study has been described in Science.
The average electrical stimulation devices, like the ones that send deep-brain stimulation (DBS) as a means of treating patients with Parkinson’s disease and depression, are constantly operating and sending impulses even if the brain activity doesn’t require it. That is why so many DBS devices cause adverse side effects like headaches. However, now that devices which respond to seizures are hitting the market, things may just get a little easier for patients.
One of these new devices is the Responsive Neurostimulator System developed by NeuroPace, which is based in Mountain View, California. This system is waiting to get approved by the FDA and is to be used in adult patients who suffer from partial-onset seizures. If this device works, it may go a long way in treating epileptics. It may be a good deal safer and more effective than prescription medications like Topamax. Topamax has been linked to serious side effects in babies whose mothers take the drug while pregnant. Babies exposed to Topamax in-utero may be born with birth defects, including PPHN, oral clefts, cleft palate, neural tube defects, spina bifida and heart, lung and brain defects. With the risk-to-benefit ratio favoring risk, many people feel that Topamax should be removed from the market or at least not be prescribed to pregnant women under any situation.
If your baby was born with any of these birth defects after being exposed to Topamax during gestation, contact Greg Jones today for a free consultation. I am experienced at fighting Topamax lawsuits and may be able to help you recover money for your baby’s injuries.